Metab

NDC

83027-0116

Route

Oral

Therapeutic class

Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Amino Acid , Amino Acid , Amino Acids [CS], Amino Acids [CS], Anti-coagulant , Blood Coagulation Factor , Blood Coagulation Factor , Calcium Chelating Activity [MoA], Calcium [CS], Calcium [CS], Calculi Dissolution Agent , Calculi Dissolution Agent , Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract , Non-Standardized Food Allergenic Extract , Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Phosphate Binder , Phosphate Binder , Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt , Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Marketing category

UNAPPROVED HOMEOPATHIC